Answers are grounded in this paper and cite their sources.
This review discusses how β cell stress affects immune targeting in type 1 diabetes, suggesting new treatment avenues.
For many years, research focused on the immune system’s role in the development of type 1 diabetes (T1D). However, mounting evidence suggests a critical involvement of intrinsic pancreatic β cell defects, particularly impaired cellular stress responses, in disease pathology. This shift in understanding is supported by the limited effectiveness of immune-targeting therapies, which have so far managed to delay, rather than prevent or cure, T1D. Here, we discuss why the immune system specifically targets β cells, how stress pathways modify the interaction between β cells and immune cells, β cell resilience, and challenges and opportunities in targeting β cell stress in T1D.
No takes yet. Share an insight, caveat, or question.
Engin et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: